Pfizer partners with IDA Foundation to provide cancer treatments to developing countries

Pfizer (NYSE:PFE) announced today that it partnered with IDA Foundation to provide access to quality cancer treatments in developing countries.

The supply agreement is slated to offer millions of patients access to innovative chemotherapy medicines for treating multiple types of cancer across 62 developing countries in Latin America, Asia, Africa and the Western Pacific region, according to a news release.

Pfizer’s latest agreement adds to its ongoing efforts to improve access to cancer treatments, as the company is already in the midst of a long-standing collaboration with the American Cancer Society and the Clinton Health Access Initiative, which provides access to Pfizer’s oncology treatment options in 11 countries in sub-Saharan Africa.

“I am proud to announce this landmark partnership, which brings us one step closer to our objective of ensuring cancer patients everywhere have sustainable access to the quality treatments they need,” Pfiz…

Read more
  • 0